0001415889-24-016064.txt : 20240607 0001415889-24-016064.hdr.sgml : 20240607 20240607182019 ACCESSION NUMBER: 0001415889-24-016064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ramasastry Saira CENTRAL INDEX KEY: 0001547959 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 241031019 MAIL ADDRESS: STREET 1: 501 CANAL BLVD. CITY: RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4-06072024_100615.xml X0508 4 2024-06-05 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001547959 Ramasastry Saira C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300 FOSTER CITY CA 94404 true false false false 1 Common Stock 2024-06-05 4 M 0 5000 14.12 A 5000 D Common Stock 2024-06-05 4 S 0 5000 25.68 D 0 D Stock Option (right to buy) 14.12 2024-06-05 4 M 0 5000 0 D 2022-05-31 2031-08-15 Common Stock 5000 2500 D Stock Option (right to buy) 26.30 2024-06-05 4 A 0 8779 0 A 2034-06-04 Common Stock 8779 8779 D Restricted Stock Units 2024-06-05 4 A 0 5703 0 A Common Stock 5703 5703 D The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting. /s/ Judit Ryvkin, Attorney-in-Fact 2024-06-07